Preventive effects of the sodium glucose cotransporter 2 inhibitor tofogliflozin on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic mice

Sodium glucose cotransporter 2 inhibitors are expected to ameliorate the abnormalities associated with metabolic syndrome including non-alcoholic fatty liver disease. In this study, we investigated the effects of the sodium glucose cotransporter 2 inhibitor tofogliflozin on the development of non-al...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Obara, Koki, Shirakami, Yohei, Maruta, Akinori, Ideta, Takayasu, Miyazaki, Tsuneyuki, Kochi, Takahiro, Sakai, Hiroyasu, Tanaka, Takuji, Seishima, Mitsuru, Shimizu, Masahito
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5601657/
https://ncbi.nlm.nih.gov/pubmed/28938561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16874
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares